Synchroneuron's Series B Round

Synchroneuron raised a round of funding on July 02, 2014. Investors include Morningside Ventures.

Synchroneuron is a biopharmaceutical company that develops new therapies for tardive dyskinesia (TD) and other related movement disorders. Tardive dyskinesia (TD) is a chronic, usually irreversible an…

Articles about Synchroneuron's Series B Round: